The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...

On Friday, Iterum Therapeutics plc (NASDAQ:ITRM) received FDA approval for its Orlynvah (sulopenem etzadroxil and probenecid) ...

When we go to seek healthcare in hospitals or other healthcare settings, getting infected with hospital-acquired infections ...

Most small kidney stones can pass on their own. However, kidney stones that are too large to pass on their own or cause ...

A YOUNG woman who thought nothing of her urinary tract infection was later told she in fact had cancer and thought she might ...

It took three ER visits and 20 hours before a hospital admitted Nevaeh Crain, 18, as her condition worsened. Doctors insisted ...

The US Food and Drug Administration (FDA) has approved Iterum Therapeutics' new drug application (NDA) for ORLYNVAH ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients, ...

The drug, Orlynvah, has been approved to treat uncomplicated UTIs in women who have limited oral antibacterial treatment options or none at all. UTI is a common bacterial infection of the bladder ...

The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections ...

An outbreak of infections linked to McDonald’s Quarter Pounders has a lot of people across the United States concerned about ...